Sign in →

Test Code B2MC Beta-2-Microglobulin (Beta-2-M), Spinal Fluid

Reporting Name

Beta-2-Microglobulin, CSF

Useful For

Evaluation of central nervous system inflammation and B-cell proliferative diseases

Performing Laboratory

Mayo Clinic Laboratories in Rochester

Specimen Type

CSF


Specimen Required


Container/Tube: Sterile vial

Specimen Volume: 1 mL

Collection Instructions: Send spinal fluid from collection vial 1.


Specimen Minimum Volume

0.5 mL

Specimen Stability Information

Specimen Type Temperature Time Special Container
CSF Refrigerated (preferred) 28 days
  Frozen  28 days
  Ambient  14 days

Reference Values

0.70-1.80 mcg/mL

Day(s) Performed

Monday through Friday

Test Classification

This test has been modified from the manufacturer's instructions. Its performance characteristics were determined by Mayo Clinic in a manner consistent with CLIA requirements. This test has not been cleared or approved by the US Food and Drug Administration.

CPT Code Information

82232 

LOINC Code Information

Test ID Test Order Name Order LOINC Value
B2MC Beta-2-Microglobulin, CSF 1951-3

 

Result ID Test Result Name Result LOINC Value
B2MC Beta-2-Microglobulin, CSF 1951-3

Clinical Information

Beta-2-microglobulin (beta-2-M) is a small membrane protein (11,800 Da) associated with the heavy chains of class I major histocompatibility complex proteins and is, therefore, on the surface of all nucleated cells. The small size allows beta-2-M to pass through the glomerular membrane, but it is almost completely reabsorbed in the proximal tubules.

 

Increased beta-2-M levels in the cerebrospinal fluid (CSF) have been shown to be of diagnostic use in non-Hodgkin lymphoma with central nervous system involvement. Elevated CSF:serum ratios seen in patients with aseptic meningoencephalitis suggest the possibility of neurologic processes including those associated with HIV infection and acute lymphoblastic leukemia. Beta-2-M measurement in multiple sclerosis seems to be of indeterminate usefulness.

Interpretation

Elevations of cerebrospinal fluid beta-2-microgobulin levels may be seen in a number of diseases including malignancies, autoimmune disease, and neurological disorders.

Cautions

Results determined by assays using different manufacturers or methods may not be comparable.

Report Available

1 to 3 days

Reject Due To

Gross hemolysis OK

Method Name

Nephelometry